New Wallabies No.10's emotional interview
We're sorry, this feature is currently unavailable. We're working to restore it. Please try again later.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Actor Gary Busey pleads guilty to sexual offence at horror convention
Actor Gary Busey has pleaded guilty to a sexual offence stemming from an appearance at a 2022 horror convention in New Jersey, according to his representatives and court records. The 81-year-old Buddy Holly star's manager, Ron Sampson, said in an email on Friday that the actor admitted to touching a woman's buttocks 'over clothing during an 8-10 second photo op'. Busey entered a guilty plea to a single count of criminal sexual contact during a virtual hearing in state court in Camden on Thursday. The actor had been accused of inappropriately touching at least three women at the Monster-Mania Convention at the Doubletree Hotel in Cherry Hill, a South Jersey town and suburb of Philadelphia. Organisers of the event acknowledged at the time that an unnamed celebrity guest was 'removed from the convention and instructed not to return' and that affected attendees were encouraged to contact police. Busey had been scheduled as a featured guest for all three days of the event. He was initially charged with two counts of fourth-degree criminal sexual contact, one count of attempted criminal sexual contact and one count of harassment. Busey's lawyer Blair Zwillman confirmed on Friday that the other charges were dropped as part of a plea deal reached with prosecutors. The actor faces up to five years' probation and fines when he is sentenced September 18. 'In my view Mr Busey was 'overcharged' probably based on his star status,' Mr Zwillman said in an email. 'He could have just as easily been charged with the disorderly persons offence of harassment by 'offensive touching'.' Camden County prosecutors did not immediately respond to an email seeking comment on Friday. Busey is widely known as a character actor, largely in supporting roles, though he came to attention and was nominated for an Oscar for best actor for playing the title role in the 1978 film The Buddy Holly Story.
Yahoo
7 minutes ago
- Yahoo
Clearbridge Health First Half 2025 Earnings: S$0.08 loss per share (vs S$0.004 loss in 1H 2024)
Clearbridge Health (Catalist:1H3) First Half 2025 Results Key Financial Results Revenue: S$4.92m (up 7.1% from 1H 2024). Net loss: S$1.35m (loss narrowed by 42% from 1H 2024). S$0.08 loss per share. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Clearbridge Health shares are down 33% from a week ago. Risk Analysis Before you take the next step you should know about the 5 warning signs for Clearbridge Health (4 are potentially serious!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
7 minutes ago
- Yahoo
Venture firm CRV raises $750M, downsizing after returning capital to investors
CRV has secured $750 million toward the 55-year-old venture firm's twentieth flagship fund, it announced on Friday. The new fund is smaller than the $1 billion early-stage fund CRV closed in the fall of 2022. At that time, the firm also announced a $500 million second Select fund, a capital pool for backing late-stage rounds of existing portfolio companies. It's no surprise that CRV is not raising a late-stage fund as part of its new fundraise. Last year, the firm told The New York Times it was returning $275 million from its $500 million Select fund to investors. The firm explained that it would not be raising another late-stage vehicle because follow-on rounds for many of its companies would lower its overall returns. CRV's limited partners were eager to back the firm's smaller fund, the firm said. It raised its entire $750 million fund in just four weeks, with demand for double that amount, CRV wrote. The latest fund will be used to invest in seed and Series A startups and it will focus on backing consumer and devtools companies. CRV is known for leading DoorDash's seed financing and the Series A rounds for both Mercury and Vercel, a cloud platform for web developers, which was last valued at $3.25 billion. Since its founding in 1970, CRV has backed over 750 startups, with 80 of them eventually going public. The firm's latest investments include CodeRabbit, a startup for AI code review, and Outtake, a company that uses AI for cybersecurity. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
